| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 179.33B | 177.31B | 129.96B | 107.19B | 89.06B | 73.12B |
| Gross Profit | 12.47B | 12.30B | 10.40B | 6.35B | 6.03B | 9.63B |
| EBITDA | 6.83B | 6.67B | 8.03B | 4.91B | 5.07B | 8.33B |
| Net Income | 4.48B | 4.27B | 4.04B | 1.86B | 2.31B | 5.44B |
Balance Sheet | ||||||
| Total Assets | 82.59B | 90.35B | 87.22B | 56.99B | 41.18B | 37.98B |
| Cash, Cash Equivalents and Short-Term Investments | 13.08B | 7.05B | 12.59B | 7.54B | 4.42B | 3.47B |
| Total Debt | 11.35B | 12.46B | 16.49B | 2.93B | 509.76M | 2.74B |
| Total Liabilities | 49.75B | 57.95B | 57.89B | 31.36B | 17.15B | 15.70B |
| Stockholders Equity | 32.84B | 32.40B | 29.33B | 25.64B | 24.03B | 22.27B |
Cash Flow | ||||||
| Free Cash Flow | 13.15B | 3.86B | 6.32B | 1.71B | 2.29B | 299.35M |
| Operating Cash Flow | 16.53B | 6.71B | 10.24B | 5.96B | 6.33B | 3.21B |
| Investing Cash Flow | -3.34B | -2.66B | -17.74B | -4.28B | -3.76B | -2.98B |
| Financing Cash Flow | -8.26B | -7.58B | 11.82B | 1.76B | -3.20B | 1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$22.75B | 11.57 | 30.71% | ― | 184.87% | 276.87% | |
62 Neutral | HK$61.29B | 19.84 | 13.73% | 1.84% | 17.48% | 10.65% | |
62 Neutral | HK$65.43B | 10.48 | 12.87% | 0.82% | 7.53% | 87.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | HK$9.24B | 6.18 | 9.13% | 3.00% | 17.21% | 166.36% | |
48 Neutral | HK$186.12M | -4.29 | -8.40% | ― | 6.32% | 28.39% | |
48 Neutral | HK$47.90B | 28.86 | 5.99% | ― | 4.33% | -10.79% |